[Federal Register Volume 74, Number 207 (Wednesday, October 28, 2009)]
[Notices]
[Pages 55588-55589]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-25887]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated June 15, 2009, and published in the Federal 
Register on June 23, 2009, (74 FR 29720), Noramco Inc., Division of 
Ortho-McNeil, Inc., 1440 Olympic Drive, Athens, Georgia 30601, made 
application by letter to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of Noroxymorphone (9668), a basic 
class of controlled substance listed in schedule II.
    The company plans to bulk manufacture the above listed controlled 
substance for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C 823(a) and determined that the registration of 
Noramco, Inc. to manufacture the listed basic class of controlled 
substance is consistent with the public interest at

[[Page 55589]]

this time. DEA has investigated Noramco, Inc. to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic class of controlled substance listed.

     Dated: October 16, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E9-25887 Filed 10-27-09; 8:45 am]
BILLING CODE 4410-09-P